A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy (Q34275427)

1 August 2017

title

A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy (English)

1 reference

1 August 2017

0 references

1 reference

1

Potters L

1 reference

1 August 2017

Cao Y

2

1 reference

1 August 2017

Calugaru E

3

1 reference

1 August 2017

Torre T

4

1 reference

1 August 2017

Fearn P

5

1 reference

1 August 2017

Wang XH

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

International Journal of Radiation Oncology Biology Physics

1 August 2017

published in

1 reference

1 August 2017

volume

50

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

605-614

1 reference

Palladium-103 brachytherapy for prostate carcinoma

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Biochemical disease-free survival following 125I prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Isotope selection for patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

The definition of biochemical failure in patients treated with definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

The signed-rank (Wilcoxon) test.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

A "natural" volume-dose histogram for brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

CT-based dosimetry for transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

A comprehensive review of prostate cancer brachytherapy: defining an optimal technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

The role of external beam irradiation in patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

The impact of edema on planning 125I and 103Pd prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901473-0

7 January 2021

10.1016/S0360-3016(01)01473-0

Identifiers

DOI

1 reference

1 August 2017

1 reference